Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
Abstract
Background Human papillomavirus (HPV) is the main cause of cervical neoplasia. Because few population-based studies have investigated the prevalence of type-specific infection in relation to cervical disease, we studied a high-risk population, estimating the prevalence of HPV infection and the risk associated with various HPV types. Methods We screened 9175 women in Guanacaste, Costa Rica, to obtain a referent standard final diagnosis, and tested 3024 women for more than 40 types of HPV with a polymerase chain reaction-based system. Results Among women with normal cytology, HPV infections peaked first in women younger than 25 years, and they peaked again at age 55 years or older with predominantly non-cancer-associated types of HPV and uncharacterized HPV types. Low-grade squamous intraepithelial lesions (LSILs) (n = 189) decreased consistently with age. The prevalence of high-grade squamous intraepithelial lesions (HSILs) (n = 128) peaked first around age 30 years and again at age 65 years or older. Seventy-three percent of LSILs were HPV positive, with HPV16 being the predominant type (16% of positive subjects). HPV was found in 89% of HSILs and 88% of cancers, with HPV16 being strongly predominant (51% and 53% of positive subjects). Virtually all HSILs and cancers had cancer-associated HPV types, with high odds ratios (ORs) and attributable fractions around 80%. Risk for HPV16 was particularly high (OR for HSILs = 320, 95% confidence interval [CI] = 97-1000; OR for cancer…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In some studies, multiple HPV infections were not associated with an increased risk of cervical cancer in women with cytological abnormalities.
“In some studies, multiple HPV infections were not associated with an increased risk of cervical cancer in women with cytological abnormalities [24–26].”
From Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples (2025) · cites this paper as [25]
The role of multiple HPV infections in the progression of cervical disease is still controversial.
“The role of multiple HPV infections in the progression of cervical disease is still controversial.”
From Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples (2025) · cites this paper as [25]
Cites
Estimating the population attributable risk for multiple risk factors using case-control data.
BRUZZI, P., GREEN, S. B., BYAR, D. P., BRINTON, L. A., & SCHAIRER, C. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114174 · Cited by 1,214 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Machalek, D. A., Grulich, A. E., Jin, F., Templeton, D. J., & Poynten, I. M. (2012) · Sexual Health · doi:10.1071/sh12043 · Cited by 59 · see citing works
Human papilloma virus, papanicolaou smears, and the college female
Moscicki, A.-B. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2004.10.005 · Cited by 24 · see citing works
Mafi, S., Theuillon, F., Meyer, S., Woillard, J.-B., Dupont, M., Rogez, S., Alain, S., & Hantz, S. (2025) · PLOS ONE · doi:10.1371/journal.pone.0320978 · Cited by 9 · see citing works
- Authors
- Herrero, R., Hildesheim, A., Bratti, C., Sherman, M. E., Hutchinson, M., Morales, J., Balmaceda, I., Greenberg, M. D., Alfaro, M., Burk, R. D., Wacholder, S., Plummer, M., & Schiffman, M.
- Affiliations
- Ministerio de Salud (CR)
- National Institutes of Health (US)
- Brown University (US)
- Costa Rican Department of Social Security (CR)
- Omnia (South Africa) (ZA)
- Yeshiva University (US)
- Centre international de recherche sur le cancer (FR)
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-03-15
- Volume
- 92
- Issue
- 6
- Pages
- 464-474
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2101809078
- Cited by
- 586
- References
- 1
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 10 · 2022: 22 · 2021: 6 · 2020: 6 · 2019: 6 · 2018: 9 · 2017: 8 · 2016: 8 · 2015: 14 · 2014: 14 · 2013: 17 · 2012: 24
- FWCI
- 36.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-54273)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- human papillomavirus, cervical neoplasia, HPV prevalence, HPV16, high-grade squamous intraepithelial lesion, low-grade squamous intraepithelial lesion, cervical cancer, menopause, attributable fraction, HPV vaccination
- MeSH terms
- Adult, Aged, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Costa Rica, Cross-Sectional Studies, Female, Humans, Middle Aged, Population Surveillance, Rural Health, Tumor Virus Infections, Prevalence, Odds Ratio, Polymerase Chain Reaction, Age Distribution, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review